FEASIBILITY OF ENDOSCOPY GUIDED FIDUCIAL MARKER PLACEMENT IN PATIENTS WITH ESOPHAGEAL TUMORS

FEASIBILITY OF ENDOSCOPY GUIDED FIDUCIAL MARKER PLACEMENT IN PATIENTS WITH ESOPHAGEAL TUMORS - esophageal fiducial study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON38822

Enrollment

Registered

2013-03-04

Start date

2013-03-06

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

endoscopy of the esophagus with implanation of 3 goldmarkers in the esophageal wall at the level of the tumor

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: esophageal cancer referred for curative radiotherapy

Exclusion criteria

Exclusion criteria: signs of perforation signs of esophageal infections coagulopathy

Design outcomes

Primary

Measure	Time frame
- feasibility and toxictiy of endoscopic placement of goldmarkers in the oesophageal wall - utility of the markers for delineation of the tumortargetvolume - utility of the markers for positional verification and correction during external radiation (image guided radiotherapy)	—

Secondary

Measure	Time frame
- analysis of tumor deformation during radiotherapy - analyses of effect of breathing on tumormobility during radiotherapy	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)